What's new

FDA OKs Eylea to Treat Diabetic Retinopathy in DME Patients
Mar 25, 2015    Industry News
ASRS Urges Horizon Blue Cross Blue Shield of NJ to Fix Elyea Claims Processing
Mar 19, 2015    Advocacy & Practice Updates
FDA Approves DORC EVA Surgical System
Mar 17, 2015    Industry News
Discussing Protocol T With DRCR.net Chair Lee Jampol, MD
Feb 24, 2015    Clinical Trials
CMS to Toughen Enforcement of MA Network Adequacy Rules
Feb 20, 2015    Advocacy & Practice Updates
ASRS Continues Fighting Humana’s Step Therapy Policy
Feb 11, 2015    Advocacy & Practice Updates
FDA OKs Lucentis for Diabetic Retinopathy in DME Patients
Feb 6, 2015    Industry News
ASRS Launches Meaningful Use FAQ
Jan 28, 2015    Advocacy & Practice Updates
Updated 2015 Medicare Physician Fee Schedule Further Cuts Retina Procedure Payments
Jan 27, 2015    Advocacy & Practice Updates
UHC Now Requiring Referrals Under AARP MedicareChoice HMO/POS Plans
Jan 14, 2015    Advocacy & Practice Updates
Health Canada Approves Argus II Retinal Prosthesis
Jan 13, 2015    Industry News
FDA Grants Breakthrough Therapy Designation to Lucentis for Diabetic Retinopathy
Dec 17, 2014    Industry News
Payers Continue Attempts to Restrict Lucentis and Eylea
Dec 17, 2014    Advocacy & Practice Updates

Retina Times

Winter 2014, Vol. 32, No. 5, Issue 57

In this issue:

What's News 
What's News Chats With Howard Schatz 

Retina Genetics
Point: There Is Evidence for Genetic Testing for AMD and Use of the AREDS Supplements

Counterpoint: There Is No Evidence for Genetic Testing for AMD and Use of the AREDS Supplements 

Road Test
Road Testing the Synergetics VersaVIT 2.0 Small-Form Vitrectomy System

Read all articles »


17th Annual Practice Management Issues Seminar
March 28-29, 2015
Dallas, Texas

ASRS 33rd Annual Meeting
July 11-14, 2015
Vienna, Austria